Notice of Establishment, 59534 [E7-20692]

Download as PDF 59534 Federal Register / Vol. 72, No. 203 / Monday, October 22, 2007 / Notices Dated: October 15, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–20692 Filed 10–19–07; 8:45 am] Dated: October 15, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–20701 Filed 10–19–07; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Centers for Disease Control and Prevention Centers for Disease Control and Prevention Notice of Establishment ebenthall on PRODPC61 with NOTICES Dated: October 15, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E7–20717 Filed 10–19–07; 8:45 am] Notice of Establishment Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Secretary, Department of Health and Human Services (HHS), announces the establishment of the Board of Scientific Counselors, National Center for Health Marketing (NCHM). This board is established to ensure that the national center has access to external viewpoints, the capacity to conduct peer review of scientific programs, and perform second level peer-review of research applications. The Board of Scientific Counselors, NCHM will advise the Secretary, HHS; and the Director, Centers for Disease Control and Prevention; concerning strategies and goals for the programs and research within the national centers; shall conduct peer-review of scientific programs; and monitor the overall strategic direction and focus of the national centers. The board, after conducting its periodic reviews, shall submit a written description of the results of the review and its recommendations to the Director, CDC. The board shall also perform secondlevel peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the national centers. For information, contact Dr. Kathleen McDuffie, Executive Secretary, Centers for Disease Control and Prevention, of the Department of Health and Human Services, 1600 Clifton Road, N.E., Mailstop E21, Atlanta, Georgia 30333, telephone 404/498–1114 or fax 404/ 498–1112. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Pursuant to the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), the Secretary, Department of Health and Human Services (HHS), announces the establishment of the Board of Scientific Counselors, National Center for Injury Prevention and Control (NCIPC). This board is established to ensure that the national center has access to external viewpoints, the capacity to conduct peer review of scientific programs, and perform second level peer-review of research applications. The Board of Scientific Counselors, NCIPC will advise the Secretary, HHS; and the Director, Centers for Disease Control and Prevention (CDC); concerning strategies and goals for the programs and research within the national centers; shall conduct peerreview of scientific programs; and monitor the overall strategic direction and focus of the national centers. The board, after conducting its periodic reviews, shall submit a written description of the results of the review and its recommendations to the Director, CDC. The board shall also perform second-level peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the national centers. For information, contact Dr. Gwendolyn Cattledge, Executive Secretary, Centers for Disease Control and Prevention, of the Department of Health and Human Services, 4770 Buford Highway, NE., Mailstop K02, Atlanta, Georgia 30341, telephone 770/ 488–4655 or fax 770/488–4422. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Ethics Subcommittee, Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC) VerDate Aug<31>2005 16:04 Oct 19, 2007 Jkt 214001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC announces the following meeting for the aforementioned subcommittee: Times and Dates: 1 p.m.–5:30 p.m., November 15, 2007. 8:30 a.m.–3:30 p.m., November 16, 2007. Place: CDC, Century Center Campus, 1825 Century Boulevard, Conference Room 1 A/B, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 70 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment periods by calling (866) 919–3560 and entering code 4168828. The public comment periods are tentatively scheduled from 4:45 p.m.–5 p.m. on November 15, 2007 and from 3 p.m.–3:15 p.m. on November 16, 2007. Purpose: The Ethics Subcommittee will provide counsel to the ACD, CDC regarding a broad range of public health ethics questions and issues arising from programs, scientists, and practitioners. Matters to be Discussed: Agenda items will include: Ethical Guidance for Public Health Emergency Preparedness and Response; Ethical Guidance for Non-Research Data Collections; and Updates on Activities relating to CDC Partnerships, Genomics Best practices, and Pandemic Influenza Preparedness. Agenda items are subject to change as priorities dictate. For security reasons, members of the public interested in attending the meeting should contact the person below. The deadline for notification of attendance is November 9, 2007. Contact Person for More Information: Drue Barrett, Ph.D., Designated Federal Official, Ethics Subcommittee, CDC, 1600 Clifton Road, NE., M/S D–50, Atlanta, Georgia 30333. Telephone (404) 639–4690. E-mail: dbarrett@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 72, Number 203 (Monday, October 22, 2007)]
[Notices]
[Page 59534]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20692]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


Notice of Establishment

    Pursuant to the Federal Advisory Committee Act, as amended (5 
U.S.C. Appendix 2), the Secretary, Department of Health and Human 
Services (HHS), announces the establishment of the Board of Scientific 
Counselors, National Center for Health Marketing (NCHM).
    This board is established to ensure that the national center has 
access to external viewpoints, the capacity to conduct peer review of 
scientific programs, and perform second level peer-review of research 
applications.
    The Board of Scientific Counselors, NCHM will advise the Secretary, 
HHS; and the Director, Centers for Disease Control and Prevention; 
concerning strategies and goals for the programs and research within 
the national centers; shall conduct peer-review of scientific programs; 
and monitor the overall strategic direction and focus of the national 
centers. The board, after conducting its periodic reviews, shall submit 
a written description of the results of the review and its 
recommendations to the Director, CDC. The board shall also perform 
second-level peer review of applications for grants-in-aid for research 
and research training activities, cooperative agreements, and research 
contract proposals relating to the broad areas within the national 
centers.
    For information, contact Dr. Kathleen McDuffie, Executive 
Secretary, Centers for Disease Control and Prevention, of the 
Department of Health and Human Services, 1600 Clifton Road, N.E., 
Mailstop E21, Atlanta, Georgia 30333, telephone 404/498-1114 or fax 
404/498-1112.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
 [FR Doc. E7-20692 Filed 10-19-07; 8:45 am]
BILLING CODE 4163-18-P